Indicated by professional guidelines for the treatment of Irritable Bowel Syndrome (IBS)
i3.1 probiotic strains P. acidilactici KABP™ 021, L. plantarum KABP™ 022 and L. plantarum KABP™ 023 attacking S. sanguinis pathogen
i3.1 is endorsed by several top-class gastrointestinal societies:
Probiotics and prebiotics guideline, as a clinically-tested treatment for IBS
German S3-guideline for IBS, as a recommended microbiota-modulator treatment
i3.1 is the only probiotic that improves visceral hypersensitivity
AB-KOLICARE presents a well-described and unique mechanism of action:
Proprietary probiotic strains naturally found in the gut of healthy individuals. Only essential ingredients
Can be taken together with anti-spasmodics to increase therapeutic benefits, specially for abdominal pain
Improves general symptoms of lactose intolerance, including pain, flatulence and diarrea
Three clinical trials with IBS and lactose intolerant patients. Safety approved by EFSA and FDA